Literature DB >> 10480840

Antithrombotic treatment for atrial fibrillation. Patients must be told full details of risks of treatment.

G Peterson.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10480840      PMCID： PMC1116556          DOI： 10.1136/bmj.319.7211.708

Source DB:  PubMed          Journal:  BMJ        ISSN： 0959-8138


× No keyword cloud information.
  4 in total

1.  A community survey of patients with atrial fibrillation: associated disabilities and treatment preferences.

Authors:  M Sudlow; R Thomson; R A Kenny; H Rodgers
Journal:  Br J Gen Pract       Date:  1998-11       Impact factor: 5.386

2.  Implementing evidence based medicine in general practice: audit and qualitative study of antithrombotic treatment for atrial fibrillation.

Authors:  A Howitt; D Armstrong
Journal:  BMJ       Date:  1999-05-15

3.  Atrial fibrillation and anticoagulation: from randomised trials to practice.

Authors:  J J Caro; P A Groome; K M Flegel
Journal:  Lancet       Date:  1993-05-29       Impact factor: 79.321

4.  Warfarin for atrial fibrillation. The patient's perspective.

Authors:  M Man-Son-Hing; A Laupacis; A O'Connor; G Wells; J Lemelin; W Wood; M Dermer
Journal:  Arch Intern Med       Date:  1996-09-09
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.